Minguez Alarcon, Lidia
- Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,481
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,481
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Minguez Alarcon, Lidia as a PI. Multi-PI records show the full award amount for context.
- 1R01ES034700-01A1R01Contact PIMale pesticide exposure, reproductive health and epigeneticsBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$733.1Kaward amount
- 5R01ES033651-02R01Contact PIExposure to phthalates and OP flame retardants and long-term maternal cardiovascular and metabolic healthBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$663.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Minguez Alarcon, Lidia as a PI.
FY2023 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardBrigham and Women's Hospital
- 2022$500K Cumulative Funding
- 2022R01 Grant Holder
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #6481